We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Kallyope

News List

Kallyope and Novo Nordisk announce collaboration to discover novel therapeutics for obesity and diabetes worldpharmanews
July 05, 2018
Kallyope, Inc and Novo Nordisk A/S today announced that they have entered into a research collaboration and option agreement to discover novel peptide therapeutics to treat obesity and diabetes. Kallyope will receive an upfront payment and research suppor
Kallyope and Novo Nordisk announce obesity and diabetes collaboration pharmafile
June 22, 2018
Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the treatment of obesity and diabetes.
Novo, Kallyope link to develop obesity, diabetes therapies pharmatimes
June 21, 2018
Novo Nordisk and Kallyope are joining forces to discover novel peptide therapeutics for obesity and diabetes.